Plasma fibronectin in acute leukaemia

Area of Science:

• Hematology
• Immunology
• Biochemistry

Background:

• Acute leukaemia is associated with immune dysregulation.
• Plasma fibronectin plays a role in immune function and wound healing.
• Infections are a major complication in acute leukaemia patients.

Purpose of the Study:

• To investigate the role of plasma fibronectin in acute leukaemia.
• To determine the relationship between fibronectin levels, disease status, and infections.
• To explore the potential of fibronectin replacement therapy.

Main Methods:

• Plasma fibronectin levels were measured in acute leukaemia patients at diagnosis and relapse.
• Fibronectin levels were correlated with tumour load, chemotherapy, neutropenia, and infection episodes.
• Preliminary trials of fibronectin replacement therapy were conducted.

Main Results:

• Low plasma fibronectin was observed at diagnosis and relapse in acute leukaemia.
• Fibronectin levels did not correlate with tumour load, chemotherapy, or neutropenia.
• Fibronectin levels strongly correlated with intercurrent infections, rapidly decreasing during severe infections.
• Fibronectin levels remained low for up to two weeks post-infection.

Conclusions:

• Plasma fibronectin levels are a potential indicator of infection in acute leukaemia patients.
• Fibronectin deficiency may contribute to increased susceptibility to infection.
• Fibronectin replacement therapy shows potential as an adjunctive treatment for acute leukaemia patients with infections.